A new immune structure found in liver tumors could improve treatment for liver cancer patients. These structures are linked ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study ...

Immune checkpoint inhibitor tumor regression may indicate which patients with hepatocellular carcinoma experience improved ...

It’s considered the leading cause of cancer deaths worldwide. SEE ALSO: ‘Many parents don’t know:’ More children, teens in Houston developing liver disease Traditional liver tumor ...

Over 800 thousand people are diagnosed with liver cancer every year worldwide, and it accounts for more than 700 thousand ...

A new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of liver cancer that occurs in young children. This effect was seen in cancer cells taken ...

Liver biochemistry (usually normal in cases of benign, uncomplicated tumors), viral serologies, and tumor markers are useful for excluding liver disease or with atypical presentations. The ...

Hepatocellular carcinoma (HCC) is a significant global health concern, particularly in regions like the Asia-Pacific, where chronic viral hepatitis ...

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

It’s considered the leading cause of cancer deaths worldwide ... it liquifies the tumor. “The liver’s an organ that can ...